Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Frankel Stanley. Director active across 1 company, notably Precision Biosciences INC. In total, 4 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €22k. Activity tracked since 26 September 2025. The latest transaction was filed on 16 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Frankel Stanley is a declarant and director of Precision Biosciences INC (XNAS). The record shows 4 filings in total, and across the 4 sampled recent filings, the activity runs from 2024-05-07 to 2025-12-17, with EUR 22302 of buys and EUR 0 of sells, and the modal transaction nature is Acquisition.